drugset / Trial / NCT00519844

Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

NCT00519844

Phase 4 Completed 5 enrolled Novo Nordisk A/S
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to assess satisfaction with growth hormone treatment in children of both sexes born small for gestational age and who are receiving growth hormone treatment.

Timeline

Start
2005-07
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic